Spectrum News: FDA proposes annual COVID boosters
UC expert says the proposal makes perfect sense
The FDA is recommending an annual COVID-19 booster shot for most adults and children. In doing so, the FDA hopes to simplify the vaccination process and avoid confusion over timing for scheduling boosters. Spectrum News interviewed Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine to get his reaction to this recommendation.
"I think it makes perfect sense from a public health perspective," said Fichtenbaum. "You really need to be able to create something that makes sense for people, and annual vaccinations are things that people can get and what we really have to do is get to the point where people are protecting themselves from the most serious consequences of COVID infection."
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine/Photo/Colleen Kelley/UC Marketing + Brand
Fichtenbaum was asked about the speed with which the first COVID-19 vaccines were developed and if this FDA recommendation quiets some of the concerns about the safety and effectiveness of the vaccine.
"I think it's a recognition that we have done a lot of studies on the safety," Fichtenbaum said. "We have studied hundreds of thousands of people worldwide using a multitude of different vaccines and we really understood more than any other vaccine under a microscope how we can define any of the adverse effects. I think we know a lot about this vaccine, and I think we can reassure the public that is generally safe and does what we want it to do, which is it prevents people from getting seriously ill and suffering the worse complications that we've seen from COVID."
Fichtenbaum was asked about the current guidance related to the COVID-19 vaccines.
"Right now, we're still under a situation where people get an initial vaccine, and then we often recommend a boost of the immunity, but we did this so rapidly under the gun of a pandemic where people were dying, as people may forget back in 2020," Fichtenbaum said. "It's already been three years and people may forget how hospitals were full, ICUs were full and so we really did this very quickly. It may be that we get to the point where the kind of vaccines we administer in the next few years will provide a little long-lasting immunity and just one vaccine is all you will need to give your immune system a boost, and that's what our hope is."
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Is there anything to fear from Hantavirus?
May 12, 2026
The University of Cincinnati's Carl Fichtenbaum, MD, professor of clinical medicine in the Division of Infectious Diseases in the Department of Internal Medicine at the College of Medicine, recently appeared on Scott Sloan's show on 700 WLW to share facts surrounding Hantavirus.
College of Medicine alumnae and faculty chair support shared alma mater
May 12, 2026
Michael A. Thomas, MD,[MS1.1] and Cincinnati OB-GYN Megan Kessler, MD, Med ’92 met in the hallways of the University of Cincinnati College of Medicine in the early 1990s.
Changes are coming for student loan borrowers with the end of the SAVE plan
May 11, 2026
Spectrum News spoke with Everett Smith, PhD, associate professor, in CECH, and Jack Miner, vice provost for enrollment management for a story about the end of the federal Saving on a Valuable Education (SAVE) plan and how it might impact millions of student loan borrowers.